Tower Research Capital (TRC)’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Tower Research Capital (TRC)’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19	Closed	-$195	–	6458
2023 Q2	$195	Sell	19 -85	-82%	-$867	﹤0.01%	5748
2023 Q1	$1K	Buy	+104	New	+$1.05K	﹤0.01%	5711
2022 Q1	–	Sell	-883	Closed	-$9K	–	6856
2021 Q4	$9K	Sell	883 -202	-19%	-$1.98K	﹤0.01%	4750
2021 Q3	$11K	Buy	+1,085	New	+$10.7K	﹤0.01%	4278

Tower Research Capital (TRC)'s DALS Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 19 shares — an estimated $195 sold.

Tower Research Capital (TRC) first reported a position in DALS in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Tower Research Capital (TRC) reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 19 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $195.
Tower Research Capital (TRC) first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 4 quarters.
Tower Research Capital (TRC)'s DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $11K in Q3 2021.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.